Aquestive Therapeutics files Q3 2025 investor presentation; no specific financial details disclosed in filing text

Aquestive Therapeutics, Inc.

Form 8-K filed on November 6, 2025, under Item 7.01 for Regulation FD disclosure.
Investor presentation attached as Exhibit 99.1, titled 'Q3 Earnings Supplemental Materials'.
Presentation available on company's website, but full content not included in provided filing text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.